ALFA Finder| Management target | Revenue FY30 |
|---|
| Revenue growth | 20% YoY growth to ₹3,219 Cr, driven by organic capacity expansion. |
|---|---|
| Margins | EBITDA margin at 26.8%, stable YoY; Saket drag temporary. |
| Demand visibility | Strong across network; occupancy steady at 77% despite new beds. |
| Management confidence | High, focused on rapid brownfield ramp-ups and capacity absorption. |
Growth
Revenue grew 20% YoY; EBITDA increased 18% with margins holding at 26.8% despite initial Saket complex expansion drag.
Outlook
Commissioning remaining 140 beds at Saket post-Diwali; ₹415 Cr investment approved for 209 additional brownfield beds.
Risks
Expansion-related operational drag and regulatory caps on oncology drug margins remain key headwinds for profitability.
Last quarter's promises, checked
Delivered
- Dwarka onco day-care: awaiting OC → services started (= BEAT)
- Max Smart EBITDA break-even guided 2nd–3rd qtr → within 3 months (= BEAT)
Partly delivered
- Vaishali 202 beds, ₹425 Cr, live pre-FY30 → 202 'added Q2', ₹415 Cr for 209 beds, 3 sites (= PARTIAL)
Missed
- Max Smart (Saket) 200 of 400 beds live in Q2 → 140 still pending, post-Diwali (= MISS)
- Oncology normalise from Q3 → share dipped, new margin caps (= MISS)
Earnings Call Transcript filed with NSE, NSE: MAXHEALTH. Summary written with AI assistance from the document.
Max Healthcare Institute Ltd: key numbers
- Share price
- ₹926.90
- Market cap
- ₹90,218 Cr
- Revenue (annual)
- ₹8,373 Cr
- Net profit (annual)
- ₹1,442 Cr
- P/E (TTM)
- 65.3×Sector 54.5×
- Promoter holding
- 23.71%+0.00% QoQ
- FII holding
- 40.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Max Healthcare Institute Ltd
All →Max Healthcare Institute Management Change
Max Healthcare appointed Dharmender Kumar as Director and Chief - Public Affairs, effective November 1, 2026. The change was approved at the October 30, 2026 board meeting.
Max Healthcare Institute Capacity Expansion: ₹97 Cr Investment
Max Healthcare will add 60 beds through two new floors at its Vaishali hospital. The Rs.97 Crore project is internally funded and due within 24 months.
- Value
- ₹97.00 Cr
- Execution
- Within 24 months
- hospital beds
- 60.0 beds
Max Healthcare Institute Capacity Expansion: ₹93 Cr Investment
Max Healthcare approved adding about 85 beds at its Noida hospital through redevelopment, at a cost of Rs 93 Crore funded by internal accruals. Commissioning is planned within 15 months.
- Value
- ₹93.00 Cr
- Execution
- Within 15 months
- hospital beds
- 85.0 beds
Max Healthcare Institute Results Update
Max Healthcare Q2 FY27 revenue rose to ₹3,219 Cr, up 20% YoY, with PAT at ₹448 Cr. Board approved ₹415 Cr capex for 209 additional beds.
- hospital beds approved for addition
- 209 beds
Max Healthcare Institute Q2 FY27 Results: Net Profit ₹414.4 Cr, Down 15.7% YoY
Max Healthcare Institute Ltd reported revenue from operations of ₹2,569 Cr (+20.3% YoY) and net profit of ₹414.4 Cr (-15.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹414.4 Cr · -15.7% YoY
Max Healthcare Institute Employee Stock Options
Max Healthcare's NRC approved 95,000 ESOPs at ₹800 exercise price under its 2022 scheme. Vesting spans 1-5 years with a 3-year post-vesting exercise window.